Hcw Biologics (HCWB) traded up 4.46 % during a 24 hours period ending at 07:35 PM Central Europe on Monday 26th. One Hcw Biologics stock can currently be bought for about USD 1.12 on popular exchanges. Current supply of Hcw Biologics stocks is 2.2 mn. Hcw Biologics has a current market capitalization of USD 2.6 mn and approximately USD 94.1 k worth of Hcw Biologics was traded on exchanges in the last 24 hours. Since last month end, Hcw Biologics has traded -41.21 % down. Simple moving average of last 200 days is at USD 4.27. The highest price of past 52 weeks was recorded at USD 23.94 on 05/20/2026. 52 weeks low was at USD 1.09 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Airwa (YYAI) traded down -4.68 % and now trades at USD 0.7. Current market capitalisation for Airwa is USD 3.1 mn.
Aptevo Therapeutics (APVO) traded flat 0 % and now trades at USD 1.53. Aptevo Therapeutics has a market capitalisation of USD 2.9 mn.
Dermata Therapeutics (DRMA) traded down -9.61 % and now trades at USD 0.73. Dermata Therapeutics has a market capitalisation of USD 3.1 mn.
20/20 Biolabs (AIDX) traded down -4 % and now trades at USD 0.24. Current market capitalisation for 20/20 Biolabs is USD 3 mn.
60 Degrees Pharma (SXTP) traded down -0.68 % and now trades at USD 0.87. 60 Degrees Pharma has a market capitalisation of USD 3.1 mn.
About Hcw Biologics
HCW Biologics Inc. is a biopharmaceutical company that specializes in discovering and developing novel immunotherapy treatments. These treatments aim to lengthen health spans by disrupting the connection between chronic, low-grade inflammation, and age-related diseases. As a global player, HCW Biologics serves customers all around the world. You can find more information about their activities and offerings on their website, www.hcwbiologics.com , or through trading on the Nasdaq stock exchange.